[Endovascular therapy options in femoro-popliteal PAD].
The endovascular treatment of femoro-popliteal PAD is still challenging. The number of endovascular procedures in this vessel segment has increased over the past years. Despite new technologies, the outcome of endovascular therapy in terms of durability is still weak. In the meantime, the latest developments are progressing, such as the combination of mechanical angioplasty and drug delivery. Additionally, there are former techniques, such as debulking by atherectomy, which have been technically improved and now contribute to modern concepts of endovascular treatment. This article provides an overview on treatment indications and technical options including the latest technical developments.
Brechtel
K
K
Dept. für diagnostische und interventionelle Radiologie, Universitätsklinik Tübingen. klaus.brechtel@med.uni-tuebingen.de
D000800:Angioplasty, Balloon / Q000295:instrumentation*; D016342:Angioplasty, Laser / Q000295:instrumentation*; D001157:Arterial Occlusive Diseases / Q000628:therapy*; D017073:Atherectomy / Q000295:instrumentation*; D019917:Blood Vessel Prosthesis Implantation; D001918:Brachytherapy / Q000295:instrumentation; D003131:Combined Modality Therapy; D054855:Drug-Eluting Stents; D004867:Equipment Design; D005081:Exercise Therapy; D005263:Femoral Artery; D006801:Humans; D007511:Ischemia / Q000628:therapy; D007866:Leg / Q000098:blood supply; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011150:Popliteal Artery; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention; D015607:Stents; D014665:Vasodilator Agents / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents